FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, particularly to a composition containing i) fenofibric acid or a physiologically acceptable salt thereof representing a salt formed with a base, ii) a binding ingredient or a combination of binding agents. Also, the invention concerns a capsule containing the above composition.
EFFECT: preparing the new composition.
27 cl, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION CONTAINING PHENOFIBRIN ACID, ITS PHYSIOLOGICALLY ACCEPTABLE SALT OR DERIVATIVE | 2003 |
|
RU2356549C2 |
| COMPOSITION AND DOSAGE FORM CONTAINING SOLID OR SEMISOLID MATRIX | 2006 |
|
RU2423997C9 |
| PHARMACEUTICALLY ACCEPTABLE SOLUBILISING COMPOSITION AND PHARMACEUTICAL DOSAGE FORM CONTAINING IT | 2007 |
|
RU2469708C2 |
| WAY OF RECEPTION OF PHARMACEUTICAL COMPOSITION IN FORM OF TABLETS CONTAINING FIBRATE AND TABLETS MADE IN THIS WAY | 2004 |
|
RU2362547C2 |
| PHARMACEUTICAL DOSED FORM, CONTAINING POLYMER CARRIER COMPOSITION | 2009 |
|
RU2519679C9 |
| SOLID MEDICINAL FORMS PREPARING BY EXTRUSION OF ISOMALT-CONTAINING POLYMER MELT AND ACTIVE SUBSTANCE | 1996 |
|
RU2197228C2 |
| HEPARIN-BASE FORMULATION | 2001 |
|
RU2278658C2 |
| OBTAINING SOLID MEASURED FORMS USING CROSS-LINKED NON-THERMOPLASTIC CARRIER | 2003 |
|
RU2344809C2 |
| SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | 1992 |
|
RU2120798C1 |
| MODIFIED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING FEBUXOSTAT | 2011 |
|
RU2602188C2 |
